4 completed, 3 recruiting, 1 terminated, 1 unknown. 9 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 4, Recruiting 3, Terminated 1, Unknown 1 |
| Phase 2 | 3 | Completed 1, Recruiting 1, Terminated 1 |
Follow Mobility Limitation: new trials by email Literature Review of Mobility Limitation trials Research Report on Mobility Limitation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Improving Mobility After Revascularization in Peripheral Artery Disease Home Based Exercise, Nitrate Rich Beetroot Juice, Attention Control - Peripheral Artery Disease, Intermittent Claudication | Phase 3 | Recruiting | Northwestern University | 386 | 2025-08-04 | 2026-10-05 |
| Impact of Brief Daily Functional Resistance Training on Lower Extremity Physical Performance Functional Activity Strength Training - Mobility Limitation | Phase 2 / Phase 3 | Recruiting | Milton S. Hershey Medical Center | 360 | 2025-04-09 | 2026-07-22 |
| SMART Exercise for PAD Supervised Treadmill Exercise, Home-Based Exercise, Nitrate-rich beetroot Juice - Peripheral Arterial Disease, Aging | Phase 3 | Recruiting | Northwestern University | 210 | 2023-09-08 | 2026-04-15 |
| Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease Adrabetadex - Niemann-Pick Disease, Type C | Phase 2 / Phase 3 | Terminated | Mandos LLC | 66 | 2015-12-23 | 2023-08-29 |
| VTS-270 to Treat Niemann-Pick Type C1 (NPC1) Disease Parts A/B: Adrabetadex, Parts A/B: Sham Control - Niemann-Pick Disease, Type C | Phase 2 / Phase 3 | Completed | Mandos LLC | 56 | 2015-10-01 | 2023-02-22 |
| Use of Whole-Body Periodic Acceleration Therapy To Aches and Pains Whole body periodic acceleration (Exer-Rest) - Pain, Stiffness | Phase 3 | Unknown | Center for Translational Medicine | 30 | 2011-08-01 | 2012-06-28 |
| Optimizing Protein Intake in Older Americans With Mobility Limitations Testosterone enanthate - Mobility Limitation | Phase 3 | Completed | Brigham and Women's Hospital | 92 | 2011-05-01 | 2021-07-29 |
| Laser Light Visual Cueing for Freezing of Gait in Parkinson's Disease Laser light (U-Step Walking Stabilizer with laser light) - Parkinson Disease | Phase 3 | Completed | Parkinson's Disease Research, Education, and Clinical Center, Philadelphia | 22 | 2003-06-01 | 2012-01-02 |
| A Comparison of Weighted Vest Exercise and Strength Training InVEST (Increased Velocity Exercise Specific to Task) - Mobility Limitations, Aging | Phase 3 | Completed | National Institute on Aging (NIA) | 160 | 2001-07-01 | 2010-07-26 |
Cognitive Dysfunction (2) · Deglutition Disorders (2) · Disease (2) · Niemann-Pick Disease, Type C (2) · Peripheral Arterial Disease (2) · Peripheral Vascular Diseases (2) · Behavior (1) · Intermittent Claudication (1) · Pain (1) · Parkinson Disease (1)
Pathological Conditions, Signs and Symptoms (9) · Signs and Symptoms (9) · Brain Diseases (3) · Central Nervous System Diseases (3) · Nervous System Diseases (3) · Arterial Occlusive Diseases (2) · Arteriosclerosis (2) · Atherosclerosis (2) · Brain Diseases, Metabolic (2) · Brain Diseases, Metabolic, Inborn (2) · Cardiovascular Diseases (2) · Cognition Disorders (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Digestive System Diseases (2) · Esophageal Diseases (2)
2-Hydroxypropyl-beta-cyclodextrin (2) · Cyclodextrins (2) · Lasers (1) · Nitrates (1) · testosterone enanthate (1)
Mandos LLC (2) · Northwestern University (2) · Brigham and Women's Hospital (1) · Center for Translational Medicine (1) · Milton S. Hershey Medical Center (1) · National Institute on Aging (NIA) (1) · Parkinson's Disease Research, Education, and Clinical Center, Philadelphia (1)
United States (9) · Australia (2) · France (2) · Germany (2) · New Zealand (2) · Singapore (2) · Turkey (Türkiye) (2) · United Kingdom (2) · Spain (1) · Switzerland (1)
Jonathan F. Bean, MD, MS (1) · Lisette Bunting-Perry, PhD, RN (1) · Maggie Nellissery, Ph.D. (1) · Shalender Bhasin, MD (1)
PMID 19414509, PMID 19854420, PMID 21143443, PMID 21636073, PMID 22289248, PMID 29188864, PMID 29532075, PMID 30932132, PMID 33417663, PMID 40525490, PMID 42035974
2015 (2), K23AG019663 (1), R01AG037547 (1), R01AG079938 (1)